The Impact of Obesity on the Incidence and Treatment of Gynecologic Cancers: A Review

Sixty-five percent of the adult population in the United States is overweight and 30% of the population is obese. There is mounting evidence that obesity is a risk factor for gynecologic cancers and may also adversely impact survival. The objectives of this review were to systematically evaluate and discuss the impact of overweight and obesity on endometrial, ovarian, and cervical cancer incidence and to review the data on the impact of obesity on treatment of these same gynecologic cancers. A PUBMED literature search was performed to identify articles in the English language that focused on the impact of obesity on cancer incidence and treatment. References of identified articles were also used to find additional related articles. Obesity profoundly increases the incidence of endometrial cancer, predominantly through the effects of unopposed estrogen. Although the data are less compelling in ovarian and cervical cancer, obesity may modestly increase the incidence of premenopausal ovarian cancer and might potentially increase cervical cancer incidence, perhaps as a result of the impact on glandular cancers or decreased screening compliance. Obese women with cancer have decreased survival; this may be disease-specific, the result of comorbid illnesses, or response to treatment. Obese women have increased surgical complications, may also have increased radiation complications, and there is no current consensus regarding appropriate chemotherapy dosing in the obese patient. Obesity is a serious health problem with significant effects on the incidence and treatment of the gynecologic malignancies. Target Audience: Obstetricians & Gynecologists, Family Physicians. Learning Objectives: After completion of this article, the reader should be able to summarize the clear evidence that obesity is a risk factor for many cancers, including gynecologic malignancies; describe the role of unopposed estrogen in gynecologic cancers; and explain that obese women overall have a poorer survival rate when afflicted with cancer.

[1]  I. Thompson.  Sabiston Textbook of Surgery, 17th Edition, Board Review , 2006 .

[2]  J. Gerberding,et al.  Correction: actual causes of death in the United States, 2000. , 2005, JAMA.

[3]  C. Badiu.  Harrison's Principles of Internal Medicine 16th ed , 2005 .

[4]  Soumitra R. Eachempati.  Sabiston Textbook of Surgery , 2004 .

[5]  P. James,et al.  Obesity: the worldwide epidemic. , 2004, Clinics in dermatology.

[6]  K. Flegal,et al.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. , 2004, JAMA.

[7]  A. Wolfberg,et al.  Role of obesity in the surgical management of advanced-stage ovarian cancer. , 2004, Journal of reproductive medicine.

[8]  A. Goldhirsch,et al.  Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[10]  J. Meyerhardt,et al.  Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  F. Larrea,et al.  Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women , 2000, Cancer Causes & Control.

[12]  H. Adami,et al.  Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) , 2000, Cancer Causes & Control.

[13]  R. Brownson,et al.  Predictors of Compliance with Recommended Cervical Cancer Screening Schedule: A Population-Based Study , 1999, Journal of Community Health.

[14]  M. Pike,et al.  Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States) , 1996, Cancer Causes & Control.

[15]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[16]  C. Bain,et al.  Body size and ovarian cancer: case–control study and systematic review (Australia) , 2004, Cancer Causes & Control.

[17]  J. Ingle,et al.  Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients , 2004, Cancer Chemotherapy and Pharmacology.

[18]  H. Adami,et al.  A prospective study of obesity and cancer risk (Sweden) , 2004, Cancer Causes & Control.

[19]  A. Partin,et al.  Re: “Obesity and hormone‐dependent tumors: cohort and co‐twin control studies based on the Swedish twin registry” , 2003 .

[20]  Anders Engeland,et al.  Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. , 2003, Journal of the National Cancer Institute.

[21]  L. Brinton,et al.  Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix , 2003, Cancer.

[22]  J. Meyerhardt,et al.  Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma , 2003, Cancer.

[23]  E. Swisher,et al.  The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. , 2003, Gynecologic oncology.

[24]  W. Navarro,et al.  Impact of obesity in the setting of high-dose chemotherapy , 2003, Bone Marrow Transplantation.

[25]  A. Furberg,et al.  Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort , 2003, International journal of cancer.

[26]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[27]  S. Feig.  IARC Handbooks of Cancer Prevention , 2003 .

[28]  A. Wolk,et al.  Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. , 2003, International journal of cancer.

[29]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[30]  Amy R. Allen,et al.  Obesity linked to some forms of cancer. , 2002, The West Virginia medical journal.

[31]  J. Wolf,et al.  Ovarian and Extraovarian Endometriosis‐Associated Cancer , 2002, Obstetrics and gynecology.

[32]  Wanghong Xu,et al.  [Obesity at different ages and endometrial cancer risk factors in urban Shanghai, China]. , 2002, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[33]  C. la Vecchia,et al.  Body size indices at different ages and epithelial ovarian cancer risk. , 2002, European journal of cancer.

[34]  D. Bodurka,et al.  Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Thun,et al.  Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  P. Dickman,et al.  Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study. , 2002, American journal of epidemiology.

[37]  D. Trichopoulos,et al.  Leptin and Body Mass Index in Relation to Endometrial Cancer Risk , 2002, Annals of Nutrition and Metabolism.

[38]  Kathleen M. Fairfield,et al.  Obesity, Weight Gain, and Ovarian Cancer , 2002, Obstetrics and gynecology.

[39]  P. Hartge,et al.  Menopausal hormone replacement therapy and risk of ovarian cancer. , 2002, JAMA.

[40]  E. Weiderpass,et al.  Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. , 2002, Journal of the National Cancer Institute.

[41]  P. Dickman,et al.  Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study. , 2001, Gynecologic oncology.

[42]  A. Zeleniuch‐Jacquotte,et al.  Role of Exogenous and Endogenous Hormones in Endometrial Cancer , 2001, Annals of the New York Academy of Sciences.

[43]  D. Allison,et al.  Body weight and cancer screening among women. , 2001, Journal of women's health & gender-based medicine.

[44]  D. Purdie,et al.  Epidemiology of endometrial cancer. , 2001, Best practice & research. Clinical obstetrics & gynaecology.

[45]  M. Thun,et al.  Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[47]  E. Swisher,et al.  Radical Hysterectomy for Cervical Cancer in Obese Women , 2000, Obstetrics and gynecology.

[48]  C. la Vecchia,et al.  Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer. , 2000, International journal of epidemiology.

[49]  C. la Vecchia,et al.  Risk factors for ovarian cancer in central Italy. , 2000, Gynecologic oncology.

[50]  T. Sellers,et al.  Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. , 2000, Archives of internal medicine.

[51]  Christina Wee,et al.  Screening for Cervical and Breast Cancer: Is Obesity an Unrecognized Barrier to Preventive Care? , 2000, Annals of Internal Medicine.

[52]  Ampil Fl,et al.  Radiotherapy for cancer of the cervix in morbidly obese women: preliminary results. , 2000 .

[53]  F. Ampil,et al.  Radiotherapy for cancer of the cervix in morbidly obese women: preliminary results. , 2000, European Journal of Gynaecological Oncology.

[54]  C. la Vecchia,et al.  Energy intake, overweight, physical exercise and colorectal cancer risk. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[55]  D. Petereit,et al.  High-dose-rate brachytherapy for medically inoperable stage I endometrial cancer. , 1998, Gynecologic oncology.

[56]  K. Carroll.  Obesity as a risk factor for certain types of cancer , 1998, Lipids.

[57]  P. Newcomb,et al.  Diabetes, body size, and risk of endometrial cancer. , 1998, American journal of epidemiology.

[58]  H. Adami,et al.  Risk for endometrial cancer in relation to occupational physical activity: A nationwide cohort study in Sweden , 1998, International journal of cancer.

[59]  S. Chow,et al.  Prognostic factors of primary adenocarcinoma of the uterine cervix. , 1998, Gynecologic oncology.

[60]  V. Moreno,et al.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas , 1998, International journal of cancer.

[61]  L. Kolonel,et al.  Diet, body size, physical activity, and the risk of endometrial cancer. , 1997, Cancer research.

[62]  J. Szer,et al.  Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey. , 1997, Leukemia & lymphoma.

[63]  G. Stuecklschweiger,et al.  Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[64]  D. Hamilton‐Fairley,et al.  Obesity and female reproductive function. , 1997, British medical bulletin.

[65]  S. Shalev,et al.  Pelvic irradiation of the obese patient: a treatment strategy involving megavoltage simulation and intratreatment setup corrections. , 1996, Medical physics.

[66]  G. Rosner,et al.  Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  R. Buller,et al.  Obesity and prognosis in endometrial cancer. , 1996, American journal of obstetrics and gynecology.

[68]  T. Sellers,et al.  Physical Activity, Waist‐to-Hip Ratio, and Other Risk Factors for Ovarian Cancer: A Follow‐up Study of Older Women , 1996, Epidemiology.

[69]  V. Siskind,et al.  Reproductive and other factors and risk of epithelial ovarian cancer: An australian case‐control study , 1995, International journal of cancer.

[70]  W. Tierney,et al.  Is obesity a barrier to physician screening for cervical cancer? , 1995, American Journal of Medicine.

[71]  K. Kerlikowske,et al.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis. , 1995, Obstetrics and gynecology.

[72]  J. Freudenheim,et al.  Body mass index, weight gain, and risk of endometrial cancer. , 1995, Nutrition and cancer.

[73]  M. Pike,et al.  Oral contraceptive use and adenocarcinoma of cervix , 1994, The Lancet.

[74]  M. Inoue,et al.  A Case‐Control Study on Risk Factors for Uterine Endometrial Cancer in Japan , 1994, Japanese journal of cancer research : Gann.

[75]  P. Blackman.  Actual causes of death in the United States. , 1994, JAMA.

[76]  J. Carstensen,et al.  Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years. , 1994, British Journal of Cancer.

[77]  J. Olsen,et al.  Obesity and cancer risk: a Danish record-linkage study. , 1994, European journal of cancer.

[78]  G. Hortobagyi,et al.  Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer , 1994, Annals of Internal Medicine.

[79]  L. Brinton,et al.  Risk factors for cervical cancer by histology. , 1993, Gynecologic oncology.

[80]  G. Morley,et al.  Prognostic factors in advanced stage squamous cell cancer of the cervix , 1993, Cancer.

[81]  L. Brinton,et al.  Past and present physical activity and endometrial cancer risk. , 1993, British Journal of Cancer.

[82]  X. Shu,et al.  Physical Activity and Risk of Endometrial Cancer , 1993, Epidemiology.

[83]  R. Baumgartner,et al.  Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[84]  G. Giles,et al.  Endometrial Cancer: Trends in Incidence and Survival: A Preventable Disease? , 1993, The Australian & New Zealand journal of obstetrics & gynaecology.

[85]  L. Brinton,et al.  Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. , 1993, Epidemiologic reviews.

[86]  A. Berchuck,et al.  Radical Hysterectomy in Obese Women , 1992, Obstetrics and gynecology.

[87]  R. Hoover,et al.  Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. , 1992, American journal of obstetrics and gynecology.

[88]  J. Fraumeni,et al.  Relation of obesity and body fat distribution to endometrial cancer in Shanghai, China. , 1992, Cancer research.

[89]  M. Maiman,et al.  Radical hysterectomy for cervical cancer: morbidity and survival in relation to weight and age. , 1992, Gynecologic oncology.

[90]  C. Perez,et al.  Principles and Practice of Gynecologic Oncology , 1992 .

[91]  C. la Vecchia,et al.  Body mass at different ages and subsequent endometrial cancer risk , 1992, International journal of cancer.

[92]  L. Marchand,et al.  Early‐age body size, adult weight gain and endometrial cancer risk , 1991, International journal of cancer.

[93]  G. Morley,et al.  A comparison of adenocarcinoma and squamous cell carcinoma of the cervix , 1991, Obstetrics and gynecology.

[94]  K. Hatch,et al.  Endometrial cancer, obesity, and body fat distribution. , 1991, Cancer research.

[95]  K. Foley,et al.  Surgical complications of obese patients with endometrial carcinoma. , 1990, Gynecologic oncology.

[96]  C. la Vecchia,et al.  Population attributable risk for endometrial cancer in northern Italy. , 1989, European journal of cancer & clinical oncology.

[97]  N. Weiss,et al.  Association of obesity and ovarian cancer in a case-control study. , 1989, American journal of epidemiology.

[98]  I. Horowitz,et al.  Epidemiology of adenocarcinoma of the cervix , 1988, Gynecologic oncology.

[99]  D. Rushing,et al.  Doxorubicin clearance in the obese. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[100]  J. Bigby.  Harrison's Principles of Internal Medicine , 1988 .

[101]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[102]  P. Björntorp,et al.  Adipose tissue distribution and female carcinomas. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1988, International journal of obesity.

[103]  J. Fraumeni,et al.  Epidemiology of cervical cancer by cell type. , 1987, Cancer research.

[104]  M. Gangemi,et al.  Obesity as a risk factor for endometrial cancer. , 1987, Clinical and experimental obstetrics & gynecology.

[105]  D. Albanes.  Caloric intake, body weight, and cancer: a review. , 1987, Nutrition and cancer.

[106]  L. Garfinkel.  Overweight and cancer. , 1985, Annals of internal medicine.

[107]  A. Lucisano,et al.  Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women. , 1984, Maturitas.

[108]  C. Enriori,et al.  Peripheral aromatization as a risk factor for breast and endometrial cancer in postmenopausal women: a review. , 1984, Gynecologic oncology.

[109]  I. Milsom,et al.  Primary adenocarcinoma of the uterine cervix. A clinical study , 1983, Cancer.

[110]  R. Greenblatt,et al.  The protective role of progesterone in the prevention of endometrial cancer. , 1982, Pathology, research and practice.

[111]  C. la Vecchia,et al.  Oestrogens and obesity as risk factors for endometrial cancer in Italy. , 1982, International journal of epidemiology.

[112]  M. Korhonen.  Epidemiological differences between adenocarcinoma and squamous cell carcinoma of the uterine cervix. , 1980, Gynecologic oncology.

[113]  W. O'Fallon,et al.  Ovarian cancer. Incidence and case‐control study , 1979, Cancer.

[114]  R. Gambrell.  THE ROLE OF HORMONES IN THE ETIOLOGY OF BREAST AND ENDOMETRIAL CANCER , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.

[115]  P. Siiteri.  Steroid hormones and endometrial cancer. , 1978, Cancer research.

[116]  A. Rimm,et al.  Association between teen-age obesity and cancer in 56,111 women: all cancers and endometrial carcinoma. , 1976, Preventive medicine.

[117]  David C. Anderson,et al.  SEX‐HORMONE‐BINDING GLOBULIN , 1974, Clinical endocrinology.

[118]  P. Siiteri,et al.  Source of estrogen production in postmenopausal women. , 1973, The Journal of clinical endocrinology and metabolism.

[119]  J. Graham,et al.  Clinical significance of adenocarcinoma of the cervix. , 1969, American journal of obstetrics and gynecology.

[120]  M. Levitz,et al.  Endometrial cancer, obesity, and estrogenic excretion in women. , 1961, American journal of obstetrics and gynecology.

[121]  R. Phillips,et al.  Carcinoma of the endometrium. A case study illustrating the evolution of the disease in a 24-year-old woman. , 1961, American journal of obstetrics and gynecology.

[122]  G. O. Lignac.  [Actual causes of death]. , 1951, Nederlands tijdschrift voor geneeskunde.